Tracey Marshall

778 total citations
11 papers, 537 citations indexed

About

Tracey Marshall is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Tracey Marshall has authored 11 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tracey Marshall's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Nuclear Structure and Function (3 papers). Tracey Marshall is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Nuclear Structure and Function (3 papers). Tracey Marshall collaborates with scholars based in United States, United Kingdom and Canada. Tracey Marshall's co-authors include Neil Senzer, Colin Love, Howard Goldsweig, John Nemunaitis, Robert S. Coffin, John A. Glaspy, Kevin J. Harrington, René González, Eric D. Whitman and Thomas Amatruda and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and IEEE Transactions on Microwave Theory and Techniques.

In The Last Decade

Tracey Marshall

11 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tracey Marshall United States 5 373 315 197 180 62 11 537
Louise Medley United Kingdom 5 364 1.0× 356 1.1× 197 1.0× 123 0.7× 112 1.8× 10 506
S. Li United States 4 156 0.4× 272 0.9× 196 1.0× 23 0.1× 22 0.4× 10 338
Hannah Chen United States 9 267 0.7× 291 0.9× 151 0.8× 102 0.6× 33 0.5× 16 453
Howard L. Kaufman United States 4 392 1.1× 221 0.7× 163 0.8× 211 1.2× 42 0.7× 9 479
R. Walker Paul Canada 8 55 0.1× 159 0.5× 175 0.9× 121 0.7× 52 0.8× 10 415
Dana Haddad United States 14 217 0.6× 319 1.0× 136 0.7× 54 0.3× 65 1.0× 29 488
Kamalakar Gulukota United States 12 77 0.2× 75 0.2× 358 1.8× 200 1.1× 35 0.6× 22 526
Roswitha Gerhards Germany 8 144 0.4× 170 0.5× 114 0.6× 150 0.8× 101 1.6× 10 374
A. Renee Stewart United States 9 256 0.7× 193 0.6× 120 0.6× 57 0.3× 37 0.6× 11 420
P. Chikoti United Kingdom 6 114 0.3× 76 0.2× 133 0.7× 224 1.2× 89 1.4× 8 370

Countries citing papers authored by Tracey Marshall

Since Specialization
Citations

This map shows the geographic impact of Tracey Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracey Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracey Marshall more than expected).

Fields of papers citing papers by Tracey Marshall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tracey Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracey Marshall. The network helps show where Tracey Marshall may publish in the future.

Co-authorship network of co-authors of Tracey Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Tracey Marshall. A scholar is included among the top collaborators of Tracey Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tracey Marshall. Tracey Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Leonard, C.T., Pilar Rivera‐Ortega, Helen Morris, et al.. (2018). What can we learn from Idiopathic Pulmonary Fibrosis Registries?. PA2195–PA2195. 1 indexed citations
2.
3.
Marshall, Tracey, et al.. (2018). Idiopathic pulmonary fibrosis: a clinical update. British Journal of General Practice. 68(670). 249–250. 1 indexed citations
4.
Marshall, Tracey, et al.. (2017). Idiopathic pulmonary fibrosis: a holistic approach to disease management in the antifibrotic age. Journal of Thoracic Disease. 9(11). 4700–4707. 18 indexed citations
5.
Gounder, Mrinal M., Alona Zer, William D. Tap, et al.. (2015). A phase 1b study with selinexor, a first in class selective inhibitor of nuclear export (SINE) in patients with advanced sarcomas: An efficacy analysis.. Journal of Clinical Oncology. 33(15_suppl). 10569–10569. 2 indexed citations
6.
Gounder, Mrinal M., Herbert H. Loong, Yelena Ustoyev, et al.. (2014). A phase 1b food effect study of the first-in-class, oral, selective inhibitor of nuclear export (SINE) selinexor (KPT-330) in patients (pts) with advanced sarcomas.. Journal of Clinical Oncology. 32(15_suppl). 10587–10587. 1 indexed citations
7.
Mahipal, Amit, Nashat Gabrail, Ammar Sukari, et al.. (2014). Clinical Activity of the Oral Selective Inhibitor of Nuclear Export (Sine) Selinexor (Kpt-330) in Patients with Head & Neck Squamos Cell Carcinoma (Hn-Scc). Annals of Oncology. 25. iv343–iv343. 3 indexed citations
8.
Senzer, Neil, Howard L. Kaufman, Thomas Amatruda, et al.. (2009). Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma. Journal of Clinical Oncology. 27(34). 5763–5771. 469 indexed citations
9.
Milowsky, Mathew I., Matthew D. Galsky, Daniel J. George, et al.. (2006). Phase I/II trial of the prostate-specific membrane antigen (PSMA)-targeted immunoconjugate MLN2704 in patients (pts) with progressive metastatic castration resistant prostate cancer (CRPC). Journal of Clinical Oncology. 24(18_suppl). 4500–4500. 12 indexed citations
10.
Milowsky, Mathew I., Matthew D. Galsky, Jack R. Lewin, et al.. (2005). Phase 1/2 dose escalation trial of the prostate-specific membrane antigen (PSMA)-targeted immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer (CRPC). Journal of Clinical Oncology. 23(16_suppl). 4615–4615. 7 indexed citations
11.
Walsh, John E., et al.. (1977). Relativistic Electron-Beam-Generated Coherent Submillimeter Wavelength Cerenkov Radiation. IEEE Transactions on Microwave Theory and Techniques. 25(6). 561–563. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louise Medley Breakdown of academic impact, for papers by S. Li Breakdown of academic impact, for papers by Hannah Chen Breakdown of academic impact, for papers by Howard L. Kaufman Breakdown of academic impact, for papers by R. Walker Paul Breakdown of academic impact, for papers by Dana Haddad Breakdown of academic impact, for papers by Kamalakar Gulukota Breakdown of academic impact, for papers by Roswitha Gerhards Breakdown of academic impact, for papers by A. Renee Stewart Breakdown of academic impact, for papers by P. Chikoti
Rankless by CCL
2026